ONCOC4, Inc.
Records under this name other than the patents ONCOC4, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 5 of 5 · Back to ONCOC4, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,629,188 | Chimeric and Humanized Anti-Human CTLA4 Monoclonal Antibodies and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,261,233 | CD80 and CD86 binding protein compositions and uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,129,299 | Mutant ANTI-CTLA-4 Antibodies with Improved Immunotherapeutic Effect But Attenuated Adverse Effects Formerly held In force · High confidence | In force | High confidence | |
| US 9,877,998 | Uses of hypoxia-inducible factor inhibitors Formerly held Lapsed on the fee record Ended Jan 30, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 30, 2026 | From the USPTO record |
| US 9,623,070 | Uses of hypoxia-inducible factor inhibitors Lapsed on the fee record Ended Apr 18, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 18, 2025 | From the USPTO record |